Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.28 USD | +1.18% | -2.28% | +27.76% |
Apr. 15 | Applied Therapeutics, Inc. Announces Management Changes | CI |
Mar. 28 | Applied Therapeutics Shares Slip 13% After FDA Extends Drug Review | DJ |
Financials (USD)
Sales 2024 * | 7.75M | Sales 2025 * | 68.12M | Capitalization | 489M |
---|---|---|---|---|---|
Net income 2024 * | -72M | Net income 2025 * | -20M | EV / Sales 2024 * | 36 x |
Net cash position 2024 * | 210M | Net cash position 2025 * | 170M | EV / Sales 2025 * | 4.68 x |
P/E ratio 2024 * |
-5.75
x | P/E ratio 2025 * |
-13.5
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.34% |
Latest transcript on Applied Therapeutics, Inc.
1 day | +1.18% | ||
1 week | -2.28% | ||
Current month | -37.06% | ||
1 month | -37.52% | ||
3 months | +47.08% | ||
6 months | +63.98% | ||
Current year | +27.76% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 45 | 16-01-19 | |
Les Funtleyder
DFI | Director of Finance/CFO | 55 | 16-05-31 |
Chief Operating Officer | 57 | Dec. 27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Skyler
BRD | Director/Board Member | 77 | 19-03-31 |
Joel Marcus
BRD | Director/Board Member | 76 | 16-12-31 |
Teena Lerner
BRD | Director/Board Member | 66 | 17-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 4.28 | +1.18% | 429,224 |
24-04-25 | 4.23 | -1.86% | 568,729 |
24-04-24 | 4.31 | -3.36% | 770,125 |
24-04-23 | 4.46 | +1.13% | 400,816 |
24-04-22 | 4.41 | +0.68% | 1,117,613 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.76% | 489M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- APLT Stock